PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice
Junya Toba(Waseda University), Toshio Ohshima(Waseda University), Miyu Nikkuni(Waseda University), Takafumi Inoue(Waseda University), Aya Yoshii(Waseda University), Naoto Watamura(UK Dementia Research Institute), Masato Ishizeki(Waseda University)
Cited by 41
Related Papers
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.
|Proceedings of the National Academy of Sciences|1996|900
Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease
|Genes to Cells|2005|411
α-Galactosidase A deficient mice: A model of Fabry disease
|Proceedings of the National Academy of Sciences|1997|370
Gene Expression Patterns of Murine Dentin Matrix Protein 1 (Dmp1) and Dentin Sialophosphoprotein (DSPP) Suggest Distinct Developmental Functions In Vivo
|Journal of Bone and Mineral Research|1997|348